Clinical Trials Browser

Phase NA × Everolimus × Genitourinary × Clear all

NCT06317298 2024-03-19

Fruquintinib Plus Everolimus as 2nd Line Therapy of ccRCC Patients Progressed Post IO and TKI Therapy

Phase NA Recruiting

Carcinoma, Renal Cell

NCT01107509 2018-04-04

Pilot Study of Neo-Adjuvant Everolimus to Treat Advanced Renal Cell Carcinoma - Analysis of Biomarkers

Phase NA Completed

Carcinoma, Renal Cell, Neoplasm Metastasis

NCT02208128 2014-08-04

MORE

Phase NA Unknown

Carcinoma, Renal Cell